Cheers, badgerkid. I have no ulterior motives with the way I'm phrasing my questions and with my very limited understanding of medical science, theres no way I'm questioning their treatments.
However high revenue, the market seems to be questioning profitability and number of treatments, from what I've read. This is why I was asking whether you considered it Q2 earnings to be better in terms of both profitability, number of treatments and revenue.
Just trying to gather information to make an informed decision. All the best.
Market Data 
Markets 
AI
